We are live on ! Find out more
GRTX

Galera Therapeutics, Inc. Common Stock
GRTX

Delisted

GRTX was delisted on the 3rd of June, 2024.

Back to rankings

1 hedge funds and large institutions have $7.13K invested in Galera Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% less funds holding

Funds holding: 36 → 1 (-35)

99% less capital invested

Capital invested by funds: $1.37M → $7.13K (-$1.36M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 35

Holders
1
Holders Change
-35
Holders Change %
-97.22%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
35
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$4.86K

Top Sellers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
-$509K
2
Blackstone Inc
Blackstone Inc
New York
-$235K
3
Aberdeen Group
Aberdeen Group
United Kingdom
-$126K
4
NFGH
Nan Fung Group Holdings
Hong Kong
-$85.9K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$62.8K

GRTX Hedge Fund Activity: Q2 2024 in Review

1 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Galera Therapeutics, Inc. Common Stock (GRTX) for Q2 2024, worth a combined $7.13K — down 99% from $1.37M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of GRTX and 0 opened new positions — a net loss of 35 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was XTX Topco, adding an estimated $4.86K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $509K sold.

  • 1 institutional investor held Galera Therapeutics, Inc. Common Stock (GRTX) as of Q2 2024, down from 36 in Q1 2024.
  • Funds reported $7.13K of Galera Therapeutics, Inc. Common Stock stock for Q2 2024, down 99% quarter-over-quarter.
  • 0 funds opened new Galera Therapeutics, Inc. Common Stock positions in Q2 2024 and 35 closed out, a net change of -35 holders.
  • The largest Galera Therapeutics, Inc. Common Stock buyer in Q2 2024 was XTX Topco, an estimated $4.86K added.
  • The largest Galera Therapeutics, Inc. Common Stock seller in Q2 2024 was GSA Capital Partners, an estimated $509K sold.

Based on aggregated 13F filings for Q2 2024.